ACHV

Achieve Life Sciences, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website achievelifesciences.com
Employees(FY) 20
ISIN US0044685008

Performance

+10.17%

-8.45%

-30.13%

-32.96%

-6.11%

YTD

-32.96%

Profile

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.

Advanced Technical Analysis

Technical Analysis of ACHV 2025-01-31

The stock indicators reflect a predominantly bearish sentiment, with the Moving Average Score at 30 indicating strong downward pressure, while the Technical Score of 36 further supports this outlook. Although the Oscillators Score of 56 suggests a neutral stance, the overall combination of scores points to a cautious market environment.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of ACHV

Stock Rank

Recent News & Updates

2025-01-23 23:14
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory(Yahoo Finance)
2025-01-09 19:30
Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors(Globenewswire)
2025-01-06 19:30
Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission(Globenewswire)
2025-01-05 19:30
Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week(Globenewswire)
2025-01-01 22:04
Should You Expect a Strong Re-rating for Achieve Life Sciences (ACHV) Post Results in Q1?(Yahoo Finance)
2024-12-08 19:30
Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer(Globenewswire)
2024-12-02 19:30
Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA(Globenewswire)
2024-11-13 19:30
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences(Globenewswire)
2024-11-08 01:01
Achieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...(Yahoo Finance)
2024-11-07 03:05
Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update(Yahoo Finance)
2024-10-23 20:00
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024(Globenewswire)
2024-10-22 20:00
Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting(Globenewswire)
2024-10-15 20:00
Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline(Globenewswire)
2024-10-09 20:00
Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting(Globenewswire)
2024-09-30 20:45
Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs(Globenewswire)
2024-08-26 04:30
Achieve Life Sciences Announces Changes in Executive Leadership and Board of Directors(Globenewswire)
2024-08-13 04:01
Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update(Globenewswire)
2024-07-30 20:00
Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence(Globenewswire)
2024-07-28 20:00
Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank(Globenewswire)
2024-07-24 20:00
Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024(Globenewswire)
2024-07-14 20:00
Milestone Pharmaceuticals Refreshes Board of Directors(Globenewswire)
2024-07-08 20:00
Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024(Globenewswire)
2024-06-30 20:00
Achieve Life Sciences Announces Addition to the U.S. Russell 3000 and Russell Microcap Indexes(Globenewswire)
2024-05-28 20:00
Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes(Globenewswire)
2024-05-16 20:00
Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting(Globenewswire)
2024-05-12 20:55
Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating(Yahoo Finance)
2024-05-10 03:47
Achieve Life Sciences Inc (ACHV) Reports Q1 2024 Financial Results(Yahoo Finance)
2024-05-10 00:41
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2024 Earnings Call Transcript(Insidermonkey)
2024-05-09 04:01
Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update(Globenewswire)
2024-05-05 23:16
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine(Globenewswire)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.